Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
WBC100 QD
DRUG
2 trials
Sponsors
Zhejiang University
, Hangzhou Weben Pharma Co., Ltd
Conditions
AML (Acute Myelogenous Leukemia
Adult Acute Myeloid Leukemia
C-Myc
Hematologic Malignancy
Refractory Acute Myeloid Leukemia
Relapsed Acute Myelogenous Leukemia
Solid Tumor
Phase 1
Clinical Trial of WBC100 on Advanced Solid Tumor
Terminated
NCT05100251
Zhejiang University
Solid Tumor
Start: 2021-12-17
End: 2026-01-06
Updated: 2026-02-17
Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
NCT07014449
Hangzhou Weben Pharma Co., Ltd
Adult Acute Myeloid Leukemia, AML (Acute Myelogenous Leukemia, C-Myc +3
Start: 2024-11-03
End: 2026-06-30
Target: 18
Updated: 2025-06-11
Related Papers
Safety and efficacy of a small-molecule c-Myc degrader WBC100 in solid tumors: A first-in-human, phase I trial.
Journal of Clinical Oncology
2025-05-28
1 citations